Delivery Order SPE2DB22D1202-SPE2DB23FJCD5

Award Date 9/20/23
Potential Completion Date 9/21/23
Potential Value $8.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,365.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the provision of Leuprolide 2-week, 14 mg/2.8 ml kits, a specialty medication. The contract is a firm fixed-price delivery order that supports the DLA Troop Support Medical program, which provides essential pharmaceutical and medical supplies to military...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,340.26, is for the delivery of Leuprolide 2WK 14 MG/2.8 ML KTS, a pharmaceutical product. The award has a completion date of May 15, 2023 and is a Firm Fixed Price Delivery Order contract. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and the contract is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,992.99 Firm Fixed Price Delivery Order contract is for the supply of Leuprolide 2WK 14 MG/2.8 ML KTS, a specialty medication, to support federal healthcare programs. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen is the prime contractor for this award and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The contract provides for the delivery of Lupron Depot 3.75 mg kits, a specialty pharmaceutical product, to support military and veterans' healthcare programs. The Delivery Order has a ceiling value of $7,592.65 and a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,104.54 for the supply of 4563875913 LUPRON DEPOT 45 MG 6MO KITS. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, on March 6, 2024, with a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,195.70 firm fixed-price delivery order is for the supply of LUPRON DEPOT 22.5 MG 3MO KITS, a specialty medication, to support military healthcare programs. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $4,155.72 and is for the delivery of Lupron Depot 3.75 mg kits, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LEUPROLIDE 2WK 14 MG/2.8 ML KTS, a specialty medication, with a ceiling value of $3,570.36 and a period of performance through February 25, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $21,476.07, is for the delivery of the pharmaceutical product Lupron Depot-Ped 11.25 mg kits. The contract has a completion date of September 21, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of Lupron Depot 3.75 mg kits to the Defense Logistics Agency (DLA). The $12,115.22 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB23FJCD5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $8,251.47, is for the delivery of Leuprolide 2WK 14 MG/2.8 ML Kits, a specialty pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 21, 2023.

This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 31, 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract did not have a set-aside designation, indicating open competition.

Generated 5/12/25, 10:40 AM